| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.08 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |